Indutrade AB (publ) (INDT) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Indutrade Q2 presentation for 2025. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Bo Anvik and CFO Patrick Johnson. Please go ahead. Welcome and good morning on our behalf as well. As usual, let's begin with the overall highlights. starting with the demand situation the order intake was stable organically unchanged from last year despite fewer working days and the uncertain market situation so underlying it was stronger than last year around half of the companies had organic order intake growth with good demand from customers within the energy sector Demand within medical technology and pharmaceuticals was aggregated on a high and stable level. Net sales decreased 4% in total, organically also minus 4%. And I will soon comment more on this. The EBITDA margin came in at 13.7%. We continued to reduce inventory during the quarter. Four acquisitions completed so far in 2025. We have prolonged some of the acquisition processes due to the general market uncertainty, but the pipeline now is very strong. Looking more specifically at the order intake and sales trends, demand was underlying stronger than last year, considering the number of working days during the quarter. We had a positive book-to-bill also this quarter with orders being 2% higher than sales. It's the second quarter in a row with a positive book-to-bill. There were continued variation between companies, segments and countries with the strongest growth in the energy sector. The demand within medical and pharmaceuticals was high and stable. Demand within infrastructure and construction, general engineering and the process industry was weaker. In terms of sales, we declin...